Mednet Logo

When do you refer a patient with metastatic ovarian cancer for upfront debulking v. neoadjuvant chemotherapy?

1 Answer
Mednet Member
Mednet MemberInvited Expert
Gynecologic Oncology · USC Keck School of Medicine
Answered on

In general, I would advise referring the patient to a gynecologic oncologist prior to chemotherapy as the decision regarding upfront versus interval debulking is complicated and best made assessing the patient and her imaging in person. However, if it is not possible to get the patient referred in a...

Join for free or sign in to see the full answer